WARNER-LAMBERT REZULIN SALES REACH $79 MIL. FOR QUARTER AS ANTIDIABETIC MARKET CONTINUES TO EXPAND; SCHERING CLARITIN TRACKING FOR $2 BIL. IN SALES IN 1997
Executive Summary
Warner-Lambert's oral antidiabetic Rezulin posted $79 mil. in sales during its first full quarter on the market, the company reported July 22.